ES2054881T3 - Pantetina como agente inhibidor de la fibrosis hepatica. - Google Patents

Pantetina como agente inhibidor de la fibrosis hepatica.

Info

Publication number
ES2054881T3
ES2054881T3 ES89100180T ES89100180T ES2054881T3 ES 2054881 T3 ES2054881 T3 ES 2054881T3 ES 89100180 T ES89100180 T ES 89100180T ES 89100180 T ES89100180 T ES 89100180T ES 2054881 T3 ES2054881 T3 ES 2054881T3
Authority
ES
Spain
Prior art keywords
pantetine
inhibiting agent
hepatic fibrosis
hepatic
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89100180T
Other languages
English (en)
Inventor
Munehiro Tomikawa
Junichiro Wakasugi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2054881T3 publication Critical patent/ES2054881T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA INVENCION SE REFIERE AL USO DE PANTERCINA COMO AGENTE INHIBIDOR DE FIBROSIS HEPATICA.
ES89100180T 1988-01-06 1989-01-05 Pantetina como agente inhibidor de la fibrosis hepatica. Expired - Lifetime ES2054881T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP106788 1988-01-06

Publications (1)

Publication Number Publication Date
ES2054881T3 true ES2054881T3 (es) 1994-08-16

Family

ID=11491185

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89100180T Expired - Lifetime ES2054881T3 (es) 1988-01-06 1989-01-05 Pantetina como agente inhibidor de la fibrosis hepatica.

Country Status (8)

Country Link
US (1) US4937266A (es)
EP (1) EP0323855B1 (es)
KR (1) KR970005324B1 (es)
AU (1) AU614569B2 (es)
CA (1) CA1318254C (es)
DE (1) DE68914468T2 (es)
ES (1) ES2054881T3 (es)
PH (1) PH26554A (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02232670A (ja) * 1989-03-06 1990-09-14 Minolta Camera Co Ltd 複写機
US5789426A (en) * 1995-01-20 1998-08-04 Cornell Research Foundation, Inc. Method for the treatment of fibroproliferative disorders by application of inhibitors of protein hydroxylation
US6046219A (en) * 1995-01-20 2000-04-04 Cornell Research Foundation, Inc. Method for the treatment of conditions mediated by collagen formation together with cell proliferation by application of inhibitors of protein hydroxylation
US5965621A (en) * 1995-08-17 1999-10-12 Allergan Methods and compositions for reducing or maintaining body weight in a mammal
WO2002098405A1 (fr) * 2001-06-05 2002-12-12 Ajinomoto Co., Inc. Inhibiteurs de fibrose du foie
WO2005089316A2 (en) 2004-03-12 2005-09-29 Intercept Pharmaceuticals, Inc. Treatment of fibrosis using fxr ligands
EP3266782B1 (en) 2013-02-07 2019-10-30 SciFluor Life Sciences, Inc. Fluorinated integrin antagonists
EP3925959A1 (en) 2015-02-19 2021-12-22 OcuTerra Therapeutics, Inc. Fluorinated derivatives of 3-(2-oxo-3-(3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl)imidazolidin-1-yl)propanoic acid and uses thereof
JP2018514568A (ja) 2015-04-30 2018-06-07 サイフルーア ライフ サイエンシズ インコーポレイテッド テトラヒドロナフチリジニルプロピオン酸誘導体およびその使用法
US10118929B2 (en) 2016-04-27 2018-11-06 Scifluor Life Sciences, Inc. Nonanoic and decanoic acid derivatives and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2110536B (en) * 1981-12-04 1986-10-29 Sogo Pharm Pharmaceutical compositions containing pantetheine-s-sulphonic acid

Also Published As

Publication number Publication date
AU614569B2 (en) 1991-09-05
AU2772389A (en) 1989-07-13
DE68914468T2 (de) 1994-07-28
EP0323855A3 (en) 1990-12-05
CA1318254C (en) 1993-05-25
KR970005324B1 (ko) 1997-04-15
EP0323855A2 (en) 1989-07-12
PH26554A (en) 1992-08-19
DE68914468D1 (de) 1994-05-19
KR890011588A (ko) 1989-08-21
US4937266A (en) 1990-06-26
EP0323855B1 (en) 1994-04-13

Similar Documents

Publication Publication Date Title
ES2192708T3 (es) Combinaciones de productos activos fungicidas.
ES2098140T3 (es) Liosferas que contienen gonadotropina.
ES2058725T3 (es) Aplicacion transdermica de 2-amino-6-n-propilamino-4,5,6,7-tetrahidrobenzotiazol.
ES2080739T3 (es) Nitro-compuestos insecticidamente activos.
ES2040727T3 (es) Un proceso para preparar una formulacion en aerosol en solucion de un analogo.
ES2085075T3 (es) Imidas y sus sales, asi como su uso como agentes tensioactivos.
ES540185A0 (es) Un sistema distribuidor para distribuir una formulacion de agente beneficioso al entorno de uso
ES2083368T3 (es) Utilizacion de disolventes de hidrocarburos halogenados como agentes de limpieza.
ES2141559T3 (es) Derivados de 2-ciano-1-sulfonamidofenil-1,3-diona y su uso como herbicidas.
HN1998000086A (es) Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
CL2004001129A1 (es) Compuestos derivados de halogenopirimidinas aril tio-eter; composicion pesticida; procedimiento de preparacion; compuestos intermediarios; y uso del compuesto como agente pesticida.
ES2192301T3 (es) Derivados de resorcinol.
DE69018118D1 (de) Verdickte wässerige Zusammensetzungen.
ES2119325T3 (es) Compuestos polienicos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
ES2067154T3 (es) Dibenzoilalquilcianohidracinas.
ES2115656T3 (es) Analogos de tocoferol cardioprotectores.
ES2043665T3 (es) 6,11-dihidro-11-(4-piperidiliden)-5h-benzo-(5,6)-ciclohepta-(1,2-b)-piridinas y composiciones y metodos de uso.
ES2120762T3 (es) Nuevas composiciones herbicidas.
MX5821E (es) El nuevo uso de caracter industrial de los 1,3-dioxolanos como agentes odorantes
ES2032428T3 (es) Procedimiento para preparar (+)-biotina.
CO4230021A1 (es) Glicosidos esteroideos, procedimientos de uso de los mismos como agentes hipocolesterolemicos y agentes antiateroscle- roticos en mamiferos.
ES2139669T3 (es) Nuevos derivados triciclicos de indan-2-mercaptoacetilamida 2-substituidos utiles como inhibidores de la encefalinasa.
ES2060293T3 (es) Nueva sustancia antiulcerosa.
ES2007310A4 (es) 3-(4-nitrofenoxi)pirazoles sustituidos y su uso como herbicidas.
IT7922664A0 (it) Derivati di-o-n-alchilici della glicerina come stimolanti di immunita'.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 323855

Country of ref document: ES